CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $3,458 | -86.1% | 3,640 | -83.8% | 0.00% | – |
Q4 2023 | $24,894 | -74.3% | 22,427 | -56.6% | 0.00% | – |
Q3 2023 | $97,047 | -48.4% | 51,621 | -1.5% | 0.00% | – |
Q2 2023 | $188,181 | +6.1% | 52,418 | -0.4% | 0.00% | – |
Q1 2023 | $177,366 | +114.9% | 52,631 | -1.1% | 0.00% | – |
Q4 2022 | $82,517 | +13.0% | 53,237 | -0.4% | 0.00% | – |
Q3 2022 | $73,000 | -37.6% | 53,473 | 0.0% | 0.00% | – |
Q2 2022 | $117,000 | -77.1% | 53,473 | -66.5% | 0.00% | – |
Q1 2022 | $510,000 | -23.8% | 159,690 | 0.0% | 0.00% | – |
Q4 2021 | $669,000 | -50.6% | 159,690 | -4.2% | 0.00% | – |
Q3 2021 | $1,353,000 | +15.1% | 166,744 | +7.1% | 0.00% | – |
Q2 2021 | $1,176,000 | -16.2% | 155,639 | -3.7% | 0.00% | – |
Q1 2021 | $1,403,000 | -11.8% | 161,661 | -19.1% | 0.00% | – |
Q4 2020 | $1,591,000 | +11.0% | 199,716 | +11.1% | 0.00% | – |
Q3 2020 | $1,433,000 | -7.0% | 179,749 | +15.4% | 0.00% | – |
Q2 2020 | $1,541,000 | +25.4% | 155,760 | -2.0% | 0.00% | – |
Q1 2020 | $1,229,000 | +164.3% | 158,974 | +31.7% | 0.00% | – |
Q4 2019 | $465,000 | -19.0% | 120,681 | +5.7% | 0.00% | – |
Q3 2019 | $574,000 | -13.2% | 114,141 | +14.1% | 0.00% | – |
Q2 2019 | $661,000 | -13.3% | 99,995 | -0.7% | 0.00% | – |
Q1 2019 | $762,000 | -3.1% | 100,687 | +3.4% | 0.00% | – |
Q4 2018 | $786,000 | -35.8% | 97,330 | +2.7% | 0.00% | – |
Q3 2018 | $1,224,000 | +29.1% | 94,814 | +14.0% | 0.00% | – |
Q2 2018 | $948,000 | +355.8% | 83,148 | +181.8% | 0.00% | – |
Q1 2018 | $208,000 | +26.8% | 29,506 | +17.1% | 0.00% | – |
Q4 2017 | $164,000 | +3.8% | 25,195 | -1.3% | 0.00% | – |
Q3 2017 | $158,000 | +43.6% | 25,519 | 0.0% | 0.00% | – |
Q2 2017 | $110,000 | -4.3% | 25,519 | -0.5% | 0.00% | – |
Q1 2017 | $115,000 | -17.9% | 25,643 | 0.0% | 0.00% | – |
Q4 2016 | $140,000 | -17.6% | 25,643 | -3.6% | 0.00% | – |
Q3 2016 | $170,000 | +26.9% | 26,592 | -9.8% | 0.00% | – |
Q2 2016 | $134,000 | +13.6% | 29,469 | -1.6% | 0.00% | – |
Q1 2016 | $118,000 | +12.4% | 29,946 | +58.6% | 0.00% | – |
Q4 2015 | $105,000 | -11.8% | 18,881 | 0.0% | 0.00% | – |
Q3 2015 | $119,000 | +2.6% | 18,881 | 0.0% | 0.00% | – |
Q2 2015 | $116,000 | -47.5% | 18,881 | +12.7% | 0.00% | – |
Q1 2015 | $221,000 | – | 16,747 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skylands Capital, LLC | 1,772,000 | $13,379,000 | 1.58% |
Sargent Investment Group, LLC | 856,315 | $6,465,000 | 1.53% |
Avenir Corp | 1,366,549 | $10,317,000 | 0.82% |
CM Management, LLC | 150,000 | $1,133,000 | 0.82% |
Winning Points Advisors, LLC | 136,900 | $1,035,000 | 0.78% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,397,000 | 0.46% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,847,000 | 0.15% |
Redmile Group, LLC | 1,304,369 | $9,848,000 | 0.15% |
Granahan Investment Management | 1,003,546 | $7,577,000 | 0.14% |
ACT CAPITAL MANAGEMENT, LLC | 35,000 | $265,000 | 0.14% |